Project Grant R01AG088643
Award Date
7/1/25
Completion Date
4/30/30
Dollars Obligated
$655K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This $1,246,362 project grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Rush University Medical Center aims to elucidate the morphology and compositional changes of the perivascular pia mater (PVS PIA) in the human brain across aging and Alzheimer's disease. The 3-year project will leverage clinical and pathological data from the Rush Religious Orders Study and Memory and Aging Project to map PVS PIA anatomy using advanced microscopy techniques. Key...
This $4,361,625 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a collaborative research initiative led by Washington University in St. Louis to investigate the molecular mechanisms underlying cerebral small vessel disease (CSVD) and its vascular contributions to dementia (VCID). The project leverages three key resources: a large collection of cerebrospinal fluid samples, human brain tissue specimens, and advanced neuroimaging...
This federal Project Grant award under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, provided by the National Institute of Neurological Disorders and Stroke (NINDS), totals $5,949,022 and will fund research to identify novel therapeutic targets for treating cerebral amyloid angiopathy (CAA) and vascular contributions to cognitive impairment and dementia (VCID) associated with Alzheimer's disease and related dementias. The project aims to leverage...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Wisconsin-Madison is focused on elucidating the role of cerebrovascular disease (CVD) pathways in cognitive decline associated with Alzheimer's disease (AD). The $640,906 award, running from June 1, 2025 to March 31, 2030, will leverage advanced neuroimaging techniques to characterize the impact of vascular disease processes, including vascular stiffness and decreased flow...
This $2,330,235 federal Project Grant award was provided by the National Institute on Aging (CFDA 93.866 Aging Research) to Rush University Medical Center in Chicago, Illinois. The goal of this 5-year study is to examine the relationship between diet, neuroinflammation, brain oxidative stress, and plasma neurodegenerative biomarkers in a diverse population to elucidate the link between diet and Alzheimer's disease/age-related dementias (AD/ADRD). The research will leverage data from four...
The National Institute on Aging (NIA) awarded a Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regenerative Research Foundation, a non-profit organization, in the amount of $1,931,965 on August 15, 2024. The goal of this award is to generate and validate a novel human induced pluripotent stem cell (iPSC) model that incorporates cerebral cortical neurons, glia, vascular endothelial cells, neural crest pericytes, and microglia to study cerebrovascular...
This $2,557,260 project grant was awarded by the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research) to The Regents of the University of California, San Francisco (UCSF) to conduct research on the lifecycle predictors and mechanisms of early Alzheimer's disease and related dementias (ADRD) among Black and White adults in their 60s. The key objectives of the 5-year project are to: 1) investigate the midlife to early late-life transition to clinical ADRD,...
This $9,631,026 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports a comprehensive analysis of the impacts of atherosclerosis on the brain's microvasculature in the context of Alzheimer's disease (AD). The research aims to investigate structural, molecular, and functional aspects of the vasculature, evaluate the secretome of key cell...
This Project Grant award, valued at $10,847,672 and funded by the National Institute on Aging's Aging Research program (CFDA 93.866), supports research on the mechanisms underlying cerebral amyloid angiopathy (CAA) and its relationship to Alzheimer's disease pathology. The primary awardee, J. David Gladstone Institutes, will conduct comprehensive studies using human postmortem brain samples, single-cell genomics, and mouse models to elucidate how microglia regulate the balance between vascular...
This federal Project Grant award of $125,373 from the National Institute on Aging's Aging Research program (CFDA 93.866) aims to elucidate the genetic architecture between Alzheimer's disease (AD) and cardio-cerebrovascular risk factors (CVRFs) in diverse racial/ethnic populations. The key objectives are to 1) identify genes that interact with CVRFs to confer AD risk, and 2) identify epigenomic and transcriptomic signatures that interact with vascular pathologies to contribute to AD risk. The...